| Literature DB >> 27060768 |
Tim Ahfeldt1, Nadia K Litterman1, Lee L Rubin2.
Abstract
Utilizing patient derived cells has enormous promise for discovering new drugs for diseases of the nervous system, a goal that has been historically quite challenging. In this review, we will outline the potential of human stem cell derived neuron models for assessing therapeutics and high-throughput screening and compare to more traditional drug discovery strategies. We summarize recent successes of the approach and discuss special considerations for developing human stem cell based assays. New technologies, such as genome editing, offer improvements to help overcome the challenges that remain. Finally, human neurons derived from patient cells have advantages for translational research beyond drug screening as they can also be used to identify individual efficacy and safety prior to clinical testing and for dissecting disease mechanisms. This article is part of a Special Issue entitled SI: Exploiting human neurons.Entities:
Keywords: Drug discovery; Human neurodegenerative disease; Stem cells
Mesh:
Year: 2016 PMID: 27060768 PMCID: PMC5053850 DOI: 10.1016/j.brainres.2016.03.051
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252